1. Home
  2. SHBI vs ENTA Comparison

SHBI vs ENTA Comparison

Compare SHBI & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shore Bancshares Inc

SHBI

Shore Bancshares Inc

N/A

Current Price

$17.75

Market Cap

601.1M

Sector

Finance

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

N/A

Current Price

$14.10

Market Cap

486.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHBI
ENTA
Founded
1876
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
601.1M
486.3M
IPO Year
1997
2012

Fundamental Metrics

Financial Performance
Metric
SHBI
ENTA
Price
$17.75
$14.10
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$19.17
$20.40
AVG Volume (30 Days)
172.4K
172.1K
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.67%
N/A
EPS Growth
34.85
29.93
EPS
1.78
N/A
Revenue
$20,853,000.00
$102,814,000.00
Revenue This Year
$9.16
$5.91
Revenue Next Year
$6.71
N/A
P/E Ratio
$10.11
N/A
Revenue Growth
N/A
16.48
52 Week Low
$11.47
$4.09
52 Week High
$20.68
$17.15

Technical Indicators

Market Signals
Indicator
SHBI
ENTA
Relative Strength Index (RSI) 34.84 51.16
Support Level $17.14 $13.39
Resistance Level $19.31 $15.52
Average True Range (ATR) 0.57 0.83
MACD -0.19 -0.06
Stochastic Oscillator 17.17 40.60

Price Performance

Historical Comparison
SHBI
ENTA

About SHBI Shore Bancshares Inc

Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: